Trends in preventive asthma medication use among children and adolescents, 1988-2008

Pediatrics

Volumn 129, Issue 1, 2012, Pages 62-69

  Kit, Brian K ^a,b,c   Simon, Alan E ^a   Ogden, Cynthia L ^a   Akinbami, Lara J ^a,c  

^a NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c U S PUBLIC HEALTH SERVICE   (United States)

Author keywords

Anti asthmatic agents; Asthma; Health care disparities; Medically uninsured; Quality indicators, health care

Indexed keywords

ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MAST CELL STABILIZER; METHYLXANTHINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; ASTHMA; CHILD; CHILD CARE; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DRUG USE; FEMALE; GENDER; HEALTH CARE DISPARITY; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RACE DIFFERENCE; SCHOOL CHILD; TREND STUDY; UNITED STATES;

EID: 84855283462     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-1513     Document Type: Article

References (61)

1. Akinbami LJ, Moorman JE, Liu X. Asthma Prevalence, Health Care Use, and Mortality: United States, 2005-2009, National Health Statistics Reports no 32. Hyattsville, MD; 2011
2. Akinbami LJ, Moorman JE, Garbe PL, Sondik EJ. Status of childhood asthma in the United States, 1980-2007. Pediatrics. 2009;123(suppl 3):S131-S145
3. National Asthma Education and Prevention Program (National Heart Lung and Blood Institute). Third Expert Panel on the Management of Asthma. Guidelines for the Diagnosis and Management of Asthma: Full Report 2007. Bethesda, MD: U.S Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute; 2007
4. Carter MC, Perzanowski MS, Raymond A, Platts-Mills TA. Home intervention in the treatment of asthma among inner-city children. J Allergy Clin Immunol. 2001;108(5):732-737 (Pubitemid 33096203)
5. Morgan WJ, Crain EF, Gruchalla RS, et al. Inner-City Asthma Study Group. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med. 2004;351(11):1068-1080 (Pubitemid 39167511)
6. Bhogal S, Zemek R, Ducharme FM. Written action plans for asthma in children. Cochrane Database Syst Rev. 2006;(3):CD005306
7. Gibson PG, Powell H. Written action plans for asthma: an evidence-based review of the key components. Thorax. 2004;59(2):94-99 (Pubitemid 38223477)
8. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343(5):332-336 (Pubitemid 30616699)
9. Senthilselvan A, Lawson JA, Rennie DC, Dosman JA. Regular use of corticosteroids and low use of short-acting beta2-agonists can reduce asthma hospitalization. Chest. 2005;127(4):1242-1251 (Pubitemid 46224287)
10. Kemp JP. Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist. Ther Clin Risk Manag. 2009;5:923-933
11. Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics. 2001;107(4):706-711 (Pubitemid 32268455)
12. Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA. 1997;277(11):887-891 (Pubitemid 27123948)
13. Calpin C, Macarthur C, Stephens D, Feldman W, Parkin PC. Effectiveness of prophylactic inhaled steroids in childhood asthma: a systemic review of the literature. J Allergy Clin Immunol. 1997;100(4):452-457 (Pubitemid 27441299)
14. Halterman JS, Yoos HL, Sidora K, Kitzman H, McMullen A. Medication use and health care contacts among symptomatic children with asthma. Ambul Pediatr. 2001;1(5):275-279 (Pubitemid 33720320)
15. Finkelstein JA, Lozano P, Farber HJ, Miroshnik I, Lieu TA. Underuse of controller medications among Medicaid-insured children with asthma. Arch Pediatr Adolesc Med. 2002;156(6):562-567 (Pubitemid 34596185)
16. Smith LA, Bokhour B, Hohman KH, et al. Modifiable risk factors for suboptimal control and controller medication underuse among children with asthma. Pediatrics. 2008;122(4):760-769
17. Warman KL, Silver EJ, Stein RE. Asthma symptoms, morbidity, and antiinflammatory use in inner-city children. Pediatrics. 2001;108(2):277-282
18. Diaz T, Sturm T, Matte T, et al. Medication use among children with asthma in East Harlem. Pediatrics. 2000;105(6):1188-1193 (Pubitemid 30346885)
19. Halterman JS, Auinger P, Conn KM, Lynch K, Yoos HL, Szilagyi PG. Inadequate therapy and poor symptom control among children with asthma: findings from a multistate sample. Ambul Pediatr. 2007;7(2):153-159 (Pubitemid 46395187)
20. Halterman JS, Aligne CA, Auinger P, McBride JT, Szilagyi PG. Inadequate therapy for asthma among children in the United States. Pediatrics. 2000;105(1 pt 3):272-276 (Pubitemid 30033250)
21. Yoos HL, Kitzman H, Halterman JS, Henderson C, Sidora-Arcoleo K, McMullen A. Treatment regimens and health care utilization in children with persistent asthma symptoms. J Asthma. 2006;43(5):385-391 (Pubitemid 43995517)
22. Crocker D, Brown C, Moolenaar R, et al. Racial and ethnic disparities in asthma medication usage and health-care utilization: data from the National Asthma Survey. Chest. 2009;136(4):1063-1071
23. US Department of Health and Human Services, Agency for Healthcare Research and Quality. 2008 National Healthcare Disparities Report. Rockville, MD: US Department of Health and Human Services, Agency for Healthcare Research and Quality; 2008
24. Lieu TA, Lozano P, Finkelstein JA, et al. Racial/ethnic variation in asthma status and management practices among children in managed Medicaid. Pediatrics. 2002;109(5):857-865 (Pubitemid 34493353)
25. Ortega AN, Gergen PJ, Paltiel AD, Bauchner H, Belanger KD, Leaderer BP. Impact of site of care, race, and Hispanic ethnicity on medication use for childhood asthma. Pediatrics. 2002;109(1). Available at: www.pediatrics.org/cgi/ content/full/109/1/e1
26. Wang LY, Zhong Y, Wheeler L. Asthma medication use in school-aged children. J Asthma. 2006;43(7):495-499 (Pubitemid 44567600)
27. Stingone JA, Claudio L. Components of recommended asthma care and the use of long-term control medication among urban children with asthma. Med Care. 2009;47(9):940-947
28. Clancy CM, Kiley JP, Weiss KB. Eliminating asthma disparities through multistakeholder partnerships. Chest. 2007;132(5):1422-1424 (Pubitemid 350155994)
29. Plan and operation of the third National Health and Nutrition Examination Survey, 1988-1994. Vital Health Stat. 1994;32:1-407
30. National Center for Health Statistics. NHANES 1999-2008. Available at: www.cdc.gov/nchs/about/major/nhanes/datalink.htm. Accessed August 1, 2011.
31. National Center for Health Statistics. NHANES Response Rates and CPS Totals. Available at: www.cdc.gov/nchs/nhanes/response-rates-CPS.htm. Accessed August 1, 2011.
32. Halterman JS, Montes G, Shone LP, Szilagyi PG. The impact of health insurance gaps on access to care among children with asthma in the United States. Ambul Pediatr. 2008;8(1):43-49
33. National Center for Health Statistics. NHANES 2007-2008 Public Data General Release File Documentation. Available at: www.cdc.gov/nchs/nhanes/ nhanes2007-2008/generaldoc-e.htm. Accessed August 1, 2011.
34. Redington AE, Howarth PH. Airway wall remodelling in asthma. Thorax. 1997;52(4):310-312 (Pubitemid 27204889)
35. Orihara K, Dil N, Anaparti V, Moqbel R. What's new in asthma pathophysiology and immunopathology? Expert Rev Respir Med. 2010;4(5):605-629
36. Bateman ED, Boushey HA, Bousquet J, et al. GOAL Investigators Group. Can guidelinedefined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med. 2004;170(8):836-844 (Pubitemid 39346477)
37. O'Byrne PM, Parameswaran K. Pharmacological management of mild or moderate persistent asthma. Lancet. 2006;368(9537):794-803 (Pubitemid 44279057)
38. Drazen JM, O'Byrne PM. Risks of long-acting beta-agonists in achieving asthma control. N Engl J Med. 2009;360(16):1671-1672
39. Chowdhury BA, Dal Pan G. The FDA and safe use of long-acting beta-agonists in the treatment of asthma. N Engl J Med. 2010;362(13):1169-1171
40. Chowdhury BA, Seymour SM, Levenson MS. Assessing the safety of adding LABAs to inhaled corticosteroids for treating asthma. N Engl J Med. 2011;364(26):2473-2475
41. Orrell-Valente JK, Jarlsberg LG, Hill LG, Cabana MD. At what age do children start taking daily asthma medicines on their own? Pediatrics. 2008;122(6). Available at: www.pediatrics.org/cgi/content/full/122/6/e1186
42. McQuaid EL, Kopel SJ, Klein RB, Fritz GK. Medication adherence in pediatric asthma: reasoning, responsibility, and behavior. J Pediatr Psychol. 2003;28(5):323-333 (Pubitemid 36750456)
43. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol. 1996;98(6 pt 1):1051-1057 (Pubitemid 27014796)
44. Gavin LA, Wamboldt MZ, Sorokin N, Levy SY, Wamboldt FS. Treatment alliance and its association with family functioning, adherence, and medical outcome in adolescents with severe, chronic asthma. J Pediatr Psychol. 1999;24(4):355-365 (Pubitemid 29354997)
45. Drotar D. Physician behavior in the care of pediatric chronic illness: association with health outcomes and treatment adherence. J Dev Behav Pediatr. 2009;30(3):246-254
46. Butz AM, Tsoukleris M, Donithan M, et al. Patterns of inhaled antiinflammatory medication use in young underserved children with asthma. Pediatrics. 2006;118(6):2504-2513 (Pubitemid 46397592)
47. Pando S, Lemière C, Beauchesne MF, Perreault S, Forget A, Blais L. Suboptimal use of inhaled corticosteroids in children with persistent asthma: inadequate prescription, poor drug adherence, or both? Pharmacotherapy. 2010;30(11):1109-1116
48. Ma J, Wang Y, Stafford RSUS. U.S. adolescents receive suboptimal preventive counseling during ambulatory care. J Adolesc Health. 2005;36(5):441
49. Chen AY, Chang RK. Factors associated with prescription drug expenditures among children: an analysis of the Medical Expenditure Panel survey. Pediatrics. 2002;109(5):728-732 (Pubitemid 34493334)
50. Mehta S, Nagar S, Aparasu R. Unmet prescription medication need in U.S. children. J Am Pharm Assoc (2003). 2009;49(6):769-776
51. Szilagyi PG, Dick AW, Klein JD, et al. Improved asthma care after enrollment in the State Children's Health Insurance Program in New York. Pediatrics. 2006;117(2):486-496 (Pubitemid 46071612)
52. Ungar WJ, Kozyrskyj A, Paterson M, Ahmad F. Effect of cost-sharing on use of asthma medication in children. Arch Pediatr Adolesc Med. 2008;162(2):104-110 (Pubitemid 351240711)
53. Ungar WJ, Paterson JM, Gomes T, et al. Relationship of asthma management, socioeconomic status, and medication insurance characteristics to exacerbation frequency in children with asthma. Ann Allergy Asthma Immunol. 2011;106(1):17-23
54. Hoilette LK, Clark SJ, Gebremariam A, Davis MM. Usual source of care and unmet need among vulnerable children: 1998-2006. Pediatrics. 2009;123(2). Available at: www.pediatrics.org/cgi/content/full/123/2/e214
55. DeVoe JE, Tillotson CJ, Wallace LS. Children's receipt of health care services and family health insurance patterns. Ann Fam Med. 2009;7(5):406-413
56. Newacheck PW, Stoddard JJ, Hughes DC, Pearl M. Health insurance and access to primary care for children. N Engl J Med. 1998;338(8):513-519 (Pubitemid 28103136)
57. FDA/Center for Drug Evaluation and Research. Drugs@FDA. Available at: www.accessdata.fda.gov/scripts/cder/drugsatfda/. Accessed August 1, 2011
58. Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff (Millwood). 2000;19(2):110-128
59. Kravitz RL, Epstein RM, Feldman MD, et al. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA. 2005;293(16):1995-2002 (Pubitemid 40570893)
60. Galbraith AA, Smith LA, Bokhour B, et al. Asthma care quality for children with minority-serving providers. Arch Pediatr Adolesc Med. 2010;164(1):38-45
61. Szefler SJ. Advances in pediatric asthma in 2010: addressing the major issues. J Allergy Clin Immunol. 2011;127(1):102-115